Hemab Therapeutics Holdings, Inc. Common Stock (COAG) vs Alpha Tau Medical Ltd (DRTS)

A side-by-side comparison of Hemab Therapeutics Holdings, Inc. Common Stock and Alpha Tau Medical Ltd across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Hemab Therapeutics Holdings, Inc. Common Stock logo
COAG
Hemab Therapeutics Holdings, Inc. Common Stock
$1.34B
$28.67HealthcareDelayed quote: Oct 6, 2026, 1:05 PM EDT
Alpha Tau Medical Ltd logo
DRTS
Alpha Tau Medical Ltd
$1.32B
$14.67HealthcareDelayed quote: Oct 6, 2026, 1:05 PM EDT

Total return — COAG vs DRTS

growth of $100 · dividends reinvested · last 1y
COAG -10.0% (-10.0%/yr)DRTS +74.4% (+74.4%/yr)DRTS compounded faster over this window
100150Start $100$90$174
COAG DRTS

COAG vs DRTS: by the numbers

  • •COAG is the larger company ($1.34B vs $1.32B market cap).

Metrics side by side

Valuation

MetricCOAGDRTS
P/B ratio2.9530.07

Profitability

MetricCOAGDRTS
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROEN/A-210.13%
ROIC-38.09%-40.47%

Growth (annualized)

MetricCOAGDRTS
Total return CAGR (5Y)N/A8.59%

Go deeper

Full COAG analysisFull DRTS analysisInteractive comparison tool

Dig into the metrics

Hemab Therapeutics Holdings, Inc. Common Stock ROEAlpha Tau Medical ROEHemab Therapeutics Holdings, Inc. Common Stock operating marginAlpha Tau Medical operating marginHemab Therapeutics Holdings, Inc. Common Stock revenue growthAlpha Tau Medical revenue growthHemab Therapeutics Holdings, Inc. Common Stock free cash flowAlpha Tau Medical free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.